Regeneron Pharmaceuticals (REGN) Earnings Call Transcripts

15 earnings calls on file for Regeneron Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.

Latest earnings call

Regeneron Pharmaceuticals Q3 2026 Earnings Call

Oct 30, 2026 8,828 words · 38 min read

Ryan CroweSenior Vice President, Investor Relations
Dr. Leonard S. SchleiferCofounder, Board Cochair, President and Chief Executive Officer
Dr. George D. YancopoulosCofounder, Board Cochair, President, and Chief Scientific Officer
Marion McCourtExecutive Vice President, Commercial

Prepared remarks and the full analyst Q&A, speaker by speaker.

Earnings calls

Calls15

LatestOct 30, 2026

SinceQ4 2019

All 15 Regeneron Pharmaceuticals transcripts Register to get access to Regeneron Pharmaceuticals’s earnings call transcripts.